Targeting N6-methyladenosine reader YTHDF1 with siRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis.

MLA

Wang, Lina, et al. “Targeting N6-Methyladenosine Reader YTHDF1 with SiRNA Boosts Antitumor Immunity in NASH-HCC by Inhibiting EZH2-IL-6 Axis.” Journal of Hepatology, vol. 79, no. 5, Nov. 2023, pp. 1185–200. EBSCOhost, https://doi.org/10.1016/j.jhep.2023.06.021.

APA

Wang, L., Zhu, L., Liang, C., Huang, X., Liu, Z., Huo, J., Zhang, Y., Zhang, Y., Chen, L., Xu, H., Li, X., Xu, L., Kuang, M., Wong, C. C., & Yu, J. (2023). Targeting N6-methyladenosine reader YTHDF1 with siRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis. Journal of Hepatology, 79(5), 1185–1200. https://doi.org/10.1016/j.jhep.2023.06.021

Chicago

Wang, Lina, Lefan Zhu, Cong Liang, Xiang Huang, Ziqin Liu, Jihui Huo, Ying Zhang, et al. 2023. “Targeting N6-Methyladenosine Reader YTHDF1 with SiRNA Boosts Antitumor Immunity in NASH-HCC by Inhibiting EZH2-IL-6 Axis.” Journal of Hepatology 79 (5): 1185–1200. doi:10.1016/j.jhep.2023.06.021.